| __timestamp | Bausch Health Companies Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 125519000 |
| Thursday, January 1, 2015 | 7853800000 | 135522000 |
| Friday, January 1, 2016 | 7063000000 | 137780000 |
| Sunday, January 1, 2017 | 6176000000 | 162135000 |
| Monday, January 1, 2018 | 6029000000 | 174885000 |
| Tuesday, January 1, 2019 | 6251000000 | 174811000 |
| Wednesday, January 1, 2020 | 5778000000 | 138761000 |
| Friday, January 1, 2021 | 6040000000 | 187695000 |
| Saturday, January 1, 2022 | 5760000000 | 581703000 |
| Sunday, January 1, 2023 | 6198000000 | 709543000 |
Unlocking the unknown
In the ever-evolving landscape of the healthcare industry, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Lantheus Holdings, Inc. and Bausch Health Companies Inc. from 2014 to 2023. Bausch Health, a major player, consistently outperformed Lantheus Holdings, with gross profits peaking in 2015 at approximately 7.9 billion. However, a notable decline followed, with profits dipping to around 5.8 billion in 2022, before a slight recovery in 2023.
Conversely, Lantheus Holdings, while starting with a modest gross profit of 125 million in 2014, demonstrated a remarkable growth trajectory. By 2023, their gross profit surged to over 700 million, marking a more than fivefold increase. This trend highlights Lantheus Holdings' strategic growth and resilience in a competitive market. Such insights are invaluable for investors and stakeholders aiming to navigate the complexities of the healthcare sector.
Gross Profit Comparison: Merck & Co., Inc. and Bausch Health Companies Inc. Trends
Gross Profit Analysis: Comparing Pfizer Inc. and Lantheus Holdings, Inc.
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Incyte Corporation vs Lantheus Holdings, Inc.: A Gross Profit Performance Breakdown
Incyte Corporation vs Bausch Health Companies Inc.: A Gross Profit Performance Breakdown
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.
Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
R&D Insights: How Lantheus Holdings, Inc. and Bausch Health Companies Inc. Allocate Funds
Key Insights on Gross Profit: Perrigo Company plc vs Bausch Health Companies Inc.